Novel SMP Responds Directly to Enzymatic Activity
By HospiMedica International staff writers Posted on 14 Mar 2019 |
Image: A shape memory polymer (SMP) that responds to enzymes could promote healing (Photo courtesy of Syracuse University).
A new study shows how a novel shape memory polymer (SMP) that responds to exposure to enzymes could soon be used to treat open wounds, infections, and cancer.
Developed by researchers at Syracuse University (NY, USA) and Bucknell University (Lewisburg, PA, USA), the new SMP includes a shape fixing component, poly(ε-caprolactone) (PCL), that is vulnerable to enzymatic degradation, and a shape memory component, Pellethane, that is enzymatically stable. As the shape fixing PCL component undergoes enzymatically-catalyzed degradation, the SMP can return to its original, programmed shape. It requires no additional trigger, such as a change in temperature, and could thus respond to cellular activity.
The researchers also analyzed material properties, shape memory performance, and cytocompatibility of the enzymatically-catalyzed shape memory response. The results demonstrate enzymatic recovery, as contraction of tensile specimens, and that shape recovery is achieved by degradation of the PCL shape-fixing phase. In addition, both the materials composing the SMP and the process of enzymatic shape recovery were cytocompatible. The study describing the SMP was published on January 15, 2019, in Acta Biomaterialia.
“We anticipate that the materials we're developing could have broad application in health care. For example, our SMPs could be used in drugs that only activate when the target cells or organ are in the desired physiological state, in scaffolds that guide tissue regeneration in response to the behavior of the regenerating tissue itself, and in decision-making biosensors that guide patient treatment more effectively,” said senior author Professor James Henderson, PhD, of Syracuse University. “We're very excited to have achieved these first enzymatically responsive SMPs.”
“The enzymatic sensitivity of the material allows it to respond directly to cell behavior. For instance, you could place it over a wound, and as the tissue remodeled and degraded it, the SMP would slowly pull the wound closed,” said lead author candidate Shelby Buffington, MSc, a biomedical engineering PhD candidate at Syracuse University. “It could be adapted to play a role in treating infections and cancer by adjusting the material's chemistry.”
SMPs include foams, scaffolds, meshes, and other polymeric substrates that have the ability to return from a deformed state (temporary shape) to their original (permanent) shape induced by an external stimulus, such as a temperature change, an electric or magnetic field, light, or a chemical solution. As well as polymers in general, SMPs also cover a wide property-range from stable to biodegradable, from soft to hard, and from elastic to rigid, depending on the structural units that constitute the SMP.
Related Links:
Syracuse University
Bucknell University
Developed by researchers at Syracuse University (NY, USA) and Bucknell University (Lewisburg, PA, USA), the new SMP includes a shape fixing component, poly(ε-caprolactone) (PCL), that is vulnerable to enzymatic degradation, and a shape memory component, Pellethane, that is enzymatically stable. As the shape fixing PCL component undergoes enzymatically-catalyzed degradation, the SMP can return to its original, programmed shape. It requires no additional trigger, such as a change in temperature, and could thus respond to cellular activity.
The researchers also analyzed material properties, shape memory performance, and cytocompatibility of the enzymatically-catalyzed shape memory response. The results demonstrate enzymatic recovery, as contraction of tensile specimens, and that shape recovery is achieved by degradation of the PCL shape-fixing phase. In addition, both the materials composing the SMP and the process of enzymatic shape recovery were cytocompatible. The study describing the SMP was published on January 15, 2019, in Acta Biomaterialia.
“We anticipate that the materials we're developing could have broad application in health care. For example, our SMPs could be used in drugs that only activate when the target cells or organ are in the desired physiological state, in scaffolds that guide tissue regeneration in response to the behavior of the regenerating tissue itself, and in decision-making biosensors that guide patient treatment more effectively,” said senior author Professor James Henderson, PhD, of Syracuse University. “We're very excited to have achieved these first enzymatically responsive SMPs.”
“The enzymatic sensitivity of the material allows it to respond directly to cell behavior. For instance, you could place it over a wound, and as the tissue remodeled and degraded it, the SMP would slowly pull the wound closed,” said lead author candidate Shelby Buffington, MSc, a biomedical engineering PhD candidate at Syracuse University. “It could be adapted to play a role in treating infections and cancer by adjusting the material's chemistry.”
SMPs include foams, scaffolds, meshes, and other polymeric substrates that have the ability to return from a deformed state (temporary shape) to their original (permanent) shape induced by an external stimulus, such as a temperature change, an electric or magnetic field, light, or a chemical solution. As well as polymers in general, SMPs also cover a wide property-range from stable to biodegradable, from soft to hard, and from elastic to rigid, depending on the structural units that constitute the SMP.
Related Links:
Syracuse University
Bucknell University
Latest Critical Care News
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration
- Preventive PCI for High-Risk Coronary Plaques Reduces Cardiac Events
- AI Diagnostic Tool Guides Rapid Diagnosis and Prediction of Sepsis
- World's First AI-Powered Sepsis Alert System Detects Sepsis in One Minute
- Smartphone Magnetometer Uses Magnetized Hydrogel to Measure Biomarkers for Disease Diagnosis
- New Technology to Revolutionize Valvular Heart Disease Care